AGP Executive Report
Last update: 8 hours agoDrug Safety: Apothecary Pharma recalled compounded tirzepatide and NAD+ injections after it could not confirm the products were sterile; contamination has not been confirmed. The recall underscores the risks of compounded medicines, which aren’t reviewed by the FDA for safety or quality before sale. Medication Warnings: The UK medicines regulator is strengthening antidepressant warnings about suicidal thoughts and sexual dysfunction, including symptoms that may continue after treatment ends. Coverage Access: Washington officials estimate about 250,000 people could lose Medicaid when new work-reporting rules begin in January, potentially disrupting prescriptions and ongoing care. Humanitarian Aid: WHO delivered 71 tonnes of medical supplies to conflict-hit northern Ethiopia, where health services face severe shortages.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.